Update 2017 What we can do to prevent & treat Richard - - PowerPoint PPT Presentation

update 2017
SMART_READER_LITE
LIVE PREVIEW

Update 2017 What we can do to prevent & treat Richard - - PowerPoint PPT Presentation

Asthma Exacerbations Update 2017 What we can do to prevent & treat Richard Hendershot, M.D., FAAAAI Asthma & Allergy Salt Lake Clinic Asthma Exacerbations Update 2017 What we can do to prevent and treat Richard Hendershot, M.D.,


slide-1
SLIDE 1

What we can do to prevent & treat

Richard Hendershot, M.D., FAAAAI Asthma & Allergy – Salt Lake Clinic

Asthma Exacerbations Update 2017

slide-2
SLIDE 2

Asthma Exacerbations Update 2017

What we can do to prevent and treat

Richard Hendershot, M.D., FAAAAI Asthma & Allergy – Salt Lake Clinic

slide-3
SLIDE 3

Asthma Exacerbations Update 2017

Etiology – increase in disease activity

slide-4
SLIDE 4

Asthma exacerbations - explode

A pressure phenomenon +/-

  • How much underlying disease/

inflammation:

  • Physiologic severity, allergy, last exacerbation,

SABA use, functional capacity (exercise), ICS use.

  • Severity of trigger (s)
  • Rhinovirus vs RSV vs influenza, SMOG, allergy

J Allergy Clin Immunol 2008;122:697-9.

slide-5
SLIDE 5

Virus is the major trigger of asthma exacerbations (70- 85% of the time based on age and risk). Note: allergy, atypical bacteria and SMOG frequently make this worse. OR 2.3 (virus only) OR 8.4 (virus + allergy)

slide-6
SLIDE 6

Is there a role for macrolides in treating exacerbations? I routinely do not b/c data is not impressive, unless already failed OCS or very severe exacerbation.

JACI 2006;117:1233-6

278 pts w/ moderate to severe asthma exacerbations tx’d w/ telithromycin + prednisone vs placebo vs prednisone. Note increased time to improvement in symptoms and decreased symptoms with addition of telithromycin.

slide-7
SLIDE 7

Asthma Exacerbations - etiology

URIs (virus) are the primary cause of an asthma exacerbation

  • Rhinovirus is the leading cause in adults & children
  • Huge seasonal peak – Fall/ September is the highest, lowest summer
  • Allergy, pollution, non-adherence amplify this.
  • Virus alone (OR 2.3) vs allergen (cat in home) exposure + virus (OR 8.4)
  • Adherence to ICS is the most effective way to decrease this risk.
  • OCS in the last 12 months highest predictor of repeat exacerbation
  • High SABA use strong predictor of exacerbations
slide-8
SLIDE 8

Asthma exacerbations – viral increase to inflammation & bronchial reactivity

URIs/ viral infections cause 85% of asthma exacerbations in peds (75% adults).

  • Rhinovirus causes 2/3 of viral triggered

exacerbations

  • Rhinovirus and/ or RSV and/or influenza all

trigger reactions but c/b SMOG, allergen, cold air, exercise, etc.

BMJ 1995;310:1225-8

slide-9
SLIDE 9

Asthma exacerbations – viral increase to inflammation & bronchial reactivity

URIs/ viral infections cause 85% in peds (75% adults) of asthma exacerbations – responsible for seasonal variation.

  • Rhinovirus causes 2/3 of viral triggered

infections

  • Why September – kids & school
  • Note: most studies indicate virus attenuates an

additional trigger.

BMJ 1995;310:1225-8

slide-10
SLIDE 10

Asthma exacerbation seasonal

  • Sept. peak is broken out by age
  • Peds 2-15 show greatest variabilty
  • Pts 16-49 yo still show a small Sept peak
  • Adults >50 is this flu season or delay in

rhinovirus getting to the elderly (no data

  • n adults over 50 for viral PCR)

Proc Am Thorac Soc 2007;4:591-6

slide-11
SLIDE 11

Ideally – measure viral infection, inflammation & reactivity at home.

  • PCR to nasal lavage is currently

impractical.

  • eNO did not work well and too

expensive for home use.

  • Home PEF failed to help as well.
  • So we use surrogate markers & we

need to be able to measure it on a population basis.

Goal – reduce exacerbations & morbidity, use markers of significance to accomplish that.

  • Controller:Reliever ratio >0.50,

patients use 2x as many controllers as relievers.

  • High SABA use correlates w/

increased morbidity.

  • Controller Rx (s) do not correlate

with exacerbations

Am J Manag Care. 2010;16(5):327-333

slide-12
SLIDE 12

Asthma exacerbations – Update 2017

What we can do to prevent & treat.

  • High use of ICS helps.
  • High need/ use of SABA is a surrogate

marker for bronchial reactivity & inflammation.

  • This is complex because it depends on the

patient/ parent’s priorities and beliefs.

  • This is a system problem & challenge.
  • There are tools available to help.
slide-13
SLIDE 13

JACI 2008;122:741-7

ICS is more effective than LTRA or lower dose ICS/ LABA

Note BADGER study See table

slide-14
SLIDE 14

JACI 2008;122:741-7 NEJM 2010;362:975-85

slide-15
SLIDE 15

Place slide text

  • here. Resize

shape behind text to properly fit content.

Overall we are doing pretty good, but for some patients can we do better?

slide-16
SLIDE 16
slide-17
SLIDE 17

3 pts hospitalized, 13 pts in ER – 12 total not meeting HEDIS, 8 ended up in ER, some hospitalized

slide-18
SLIDE 18

What do we do ? Utah stats per year:

  • 40 deaths
  • >1500

hospitalizations

  • >7000 ED visits
slide-19
SLIDE 19

Asthma exacerbations – key messages

Factors we CANNOT change.

  • Before puberty boys exacerbate >

girls.

  • After puberty, females exacerbate

more, get sicker, hospitalized longer

  • Predictable seasonal epidemics
  • Most exacerbations virally

triggered. Factors we CAN change

  • Synergistic relationship between viral

infection/ allergy sensitization & exposure & exacerbations.

  • Frequent exacerbations indicate

comorbidity especially psychosocial factors.

  • ICS + LABA helps, LABA without ICS is
  • inappropriate. Off-label of PRN ICS/

formoteral has proven efficacy.

  • +LTRA in peds helps reduce fall

exacerbations.

JACI 2008;122:662-8

slide-20
SLIDE 20

Am J Manag Care. 2010;16(5):327-333

Big Picture, the more controller med used regularly (ICS, ICS/LABA or LTRA taken) and less SABA required regularly to treat asthma the lower the risk of an exacerbation. Distribution of a controller does not help.

slide-21
SLIDE 21

2 addressable problems:

  • 1. Address comorbidities including

psycho-social.

  • 2. Align goals & expectations

between docs & pts. **Key relationships

Asthma exacerbations – what can we do about them?

slide-22
SLIDE 22

Comorbidities:

  • 1. Psychosocial – cost, divorce, child

in charge, poor technique, etc.

  • 2. Allergy – cat/dog/ guinea pig/ bird
  • 3. Sinusitis
  • 4. Tobacco/ SMOG
  • 5. AERD
  • 6. GERD
  • 7. Hyper-eosinophilia, etc.

Asthma exacerbations – what can we do about them?

slide-23
SLIDE 23

Psychosocial: Relationships, relationships, relationships (care manager to track), doctor to educate and create a plan Discussion on approaches

  • Divorce?
  • Cost?
  • Child in charge of therapy?
  • Poor technique?
  • Other problems with discussion . . .

Asthma exacerbations – what can we do about them?

slide-24
SLIDE 24

Other comorbidities:

  • 1. Allergy – cat/dog/ guinea pig/ bird,
  • nly about 5% get rid of their pets so

modify environment and trial AIT

  • 2. Sinusitis – consider above too
  • 3. Tobacco/ SMOG – quit, avoid, stay

indoors on bad days.

  • 4. AERD – ASA desensitization, LTRA
  • 5. GERD – rare, worth a trial
  • 6. Hyper-eosinophilia, etc, new med, etc

Asthma exacerbations – what can we do about them?

slide-25
SLIDE 25
slide-26
SLIDE 26

Goals & Expectations/ pt perceptions:

  • 1. Not allergic to my dog or cat
  • 2. OCS 2-5 times a year OK.
  • 3. ED/ hospitalization twice a year OK.
  • 4. Fear of steroids – ICS vs OCS
  • 5. SABA use 2-4 times a day OK.
  • 6. Preference for naturopathic therapy,

standard medical care is harmful.

  • 7. Coughing after exertion – normal.

**Relationships key to this

Asthma exacerbations – what can we do about them?

slide-27
SLIDE 27

Another great idea: My brother in law worked with a farmer in upstate New York who did this with his tractor. It was terrifying and awesome at the same time.

slide-28
SLIDE 28

Goals & Expectations/ pt perceptions:

  • --OCS 2-5 times a year OK/ ED hospitalizations

OK. Peds OCS use:

  • short term crazy & hyperactive (hangry)
  • Long term – loss of height, see adult long

term Adult OCS use:

  • Short term – cranky/ hungry (extra hangry)
  • long term - DM-II, osteoporosis, compression

fractures, loss of FEV1

Asthma exacerbations – what can we do about them?

slide-29
SLIDE 29

Goals & Expectations/ pt perceptions Fear of all steroids

  • Yes, corticosteroids are bad – but dose

matters.

  • Pred 60mg QD x 5 days = 300mg
  • Fluticase ICS 200mcg QD x 365 days x

10% efficiency = 7300 mcg = 7.3mg

  • 300mg/7.3mg = 41 fold higher dose per

year with 1 exacerbation per year for OCS

Asthma exacerbations – what can we do about them?

slide-30
SLIDE 30

Goals & Expectations/ pt perceptions High SABA use OK

  • Asthma is 3 things: bronchial

reactivity, inflammation, mucus

  • SABA only treats bronchial

reactivity and leaves other alone

  • Sole SABA use (no ICS) correlates

with increased risk of death, hospitalizations, ED, decreased exercise capacity

Asthma exacerbations – what can we do about them?

slide-31
SLIDE 31

Goals & Expectations/ pt perceptions:

  • 1. Preference for naturopathic

therapy, standard medical care is harmful – ideas? My experience supports patience and a good relationship is key here.

  • 2. Coughing after exertion, I avoid or

have my child avoid exercise – education, all asthmatics should be so well treated they can exercise as much as they prefer.

Asthma exacerbations – what can we do about them?

slide-32
SLIDE 32

Asthma Exacerbations Update 2017

Big picture: Intermountain Healthcare as a whole is doing well w/ HEDIS. However, pts are still severely exacerbating & those are the pts failing.

  • Success = High ICS/ LTRA or ICS+LABA

use with low regular SABA use.

  • Physician & care manager relationships

& communication are key to making this happen. Cute picture, but if this occurs it largely means we failed as a

  • system. WE CAN DO BETTER.
slide-33
SLIDE 33

Asthma Exacerbations Update 2017

  • Discussion & questions & ideas.
  • I want your ideas and your experience

with how this can be done better as individuals and as a system.